Introduction to new oral anticoagulants (NOAC's)

Rohan Jayasinghe; Ryan Markha; Kais Hyasat; Geoff Adsett

doi:10.36478/tcard.2014.7.10

Introduction to new oral anticoagulants (NOAC's)

Rohan Jayasinghe^*, Ryan Markha, Kais Hyasat, Geoff Adsett

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.

Original language	English
Pages (from-to)	7-10
Number of pages	4
Journal	Cardiology (Pakistan)
Volume	9
Issue number	1
DOIs	https://doi.org/10.36478/tcard.2014.7.10
Publication status	Published - 2014
Externally published	Yes

Keywords

NOAC's
Physicians
Potential
Pubmed databases
Rivaroxaban

Access to Document

10.36478/tcard.2014.7.10

Cite this

@article{e319b20ddeeb4ac4aa6d1b87dea20ef3,

title = "Introduction to new oral anticoagulants (NOAC's)",

abstract = "To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.",

keywords = "NOAC's, Physicians, Potential, Pubmed databases, Rivaroxaban",

author = "Rohan Jayasinghe and Ryan Markha and Kais Hyasat and Geoff Adsett",

year = "2014",

doi = "10.36478/tcard.2014.7.10",

language = "English",

volume = "9",

pages = "7--10",

journal = "Cardiology (Pakistan)",

issn = "1811-8194",

publisher = "Grace Publications Network",

number = "1",

}

TY - JOUR

T1 - Introduction to new oral anticoagulants (NOAC's)

AU - Jayasinghe, Rohan

AU - Markha, Ryan

AU - Hyasat, Kais

AU - Adsett, Geoff

PY - 2014

Y1 - 2014

N2 - To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.

AB - To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.

KW - NOAC's

KW - Physicians

KW - Potential

KW - Pubmed databases

KW - Rivaroxaban

UR - http://www.scopus.com/inward/record.url?scp=84903937060&partnerID=8YFLogxK

UR - http://medwelljournals.com/abstract/?doi=tcard.2014.7.10

U2 - 10.36478/tcard.2014.7.10

DO - 10.36478/tcard.2014.7.10

M3 - Article

AN - SCOPUS:84903937060

SN - 1811-8194

VL - 9

SP - 7

EP - 10

JO - Cardiology (Pakistan)

JF - Cardiology (Pakistan)

IS - 1

ER -

Introduction to new oral anticoagulants (NOAC's)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this